News Headlines

  1. Piramal Pharma Solutions Invests $10 Million USD To Expand Its High Potency API Capability In Its Riverview Facility In U.S.
    6/20/2019

    Piramal Pharma Solutions (PPS), a leading Contract Development and Manufacturing Organization (CDMO), today announced the Grand Opening of a new wing at the Riverview site dedicated to the production of high potency active pharmaceutical ingredients (HPAPIs) with low Occupational Exposure Levels (OELs).

  2. Catalent To Purchase Bristol-Myers Squibb Manufacturing Facility In Anagni, Italy
    6/19/2019

    Bristol-Myers Squibb Company and Catalent, Inc., recently announced that Catalent has agreed to purchase Bristol-Myers Squibb’s oral solid, biologics, and sterile product manufacturing and packaging facility in Anagni, Italy.

  3. Seqens To Unveil New Innovation And Development Center Of Excellence
    6/18/2019

    Seqens, an integrated global leader in pharmaceutical synthesis and specialty ingredients. will open a 34,000-square-meter lab recently that is close to Paris and will serve as the company’s center of excellence in its Porcheville facility.

  4. IVERIC Bio Enters Into Strategic Manufacturing Relationship With Catalent's Paragon Gene Therapy For Orphan Inherited Retinal Diseases
    6/17/2019

    IVERIC bio, Inc. and Catalent Biologics, recently announced that they have entered into an agreement for production and manufacturing of GMP-grade adeno-associated virus (AAV) vector for IVERIC bio’s gene therapy product candidates, IC-100 for the treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) and IC-200 for the treatment of BEST1 related retinal diseases.

  5. LSNE Completes Acquisition Of Sterile Injectables Manufacturing Facility Located In León, Spain
    6/17/2019

    Lyophilization Services of New England (LSNE), a leading contract development and manufacturing organization (CDMO), announced today the acquisition of a sterile injectables manufacturing facility located in León, Spain. The site, LSNE-León, will complement LSNE's existing full-service manufacturing capabilities and expand its reach into Europe.

  6. LSNE Completes Acquisition Of Sterile Injectables Manufacturing Facility In Spain
    6/17/2019

    Lyophilization Services of New England (LSNE), a leading contract development and manufacturing organization (CDMO), announced recently the acquisition of a sterile injectables manufacturing facility located in León, Spain.

  7. Lonza To Expand HPAPI Development And Manufacturing Capacity
    6/13/2019

    Lonza, a CDMO partner to the biopharma industry, recently announced an investment in a major expansion of Highly Potent API (HPAPI) capacity at its Visp, CH site to meet increased market demand.

  8. Tergus Pharma Announces New Commercial Manufacturing Facility And Partnership With Great Point Partners
    6/6/2019

    Tergus Pharma (“Tergus”), an end-to-end service provider for topical pharmaceutical research, drug development, testing and manufacturing, recently has announced a 100,000-square-foot building for its new headquarters and plans to invest to expand into commercial manufacturing.

  9. FUJIFILM Corporation Announces The Introduction Of A Novel, Fully Integrated Continuous Production System For The Manufacture Of Biopharmaceuticals
    6/5/2019

    FUJIFILM Corporation (President: Kenji Sukeno), recently announced an initial $10M USD investment to establish a full scale, fully integrated continuous processing facility for non-GMP manufacture of biopharmaceuticals at its FUJIFILM Diosynth Biotechnologies, Billingham, UK location.

  10. Evotec And Celgene Further Expand iPSC Collaboration Including New Cell Type
    6/5/2019

    Evotec SE announced recently that its strategic alliance with Celgene Corporation ("Celgene") has been expanded to include a new cell type triggering a payment of $9.0M to Evotec.